Search

everythinglearnresearchcommunity

for

Search:↓

Temozolomide improves survival in grade III glioma patients without harming quality of life.

3D-bioprinting models of pancreatic cancer could help personalize treatments but need more testing.

Taking spironolactone doesn't increase the chance of breast cancer coming back.

Activating Sonic Hedgehog signaling in cancer stroma may help treat basal cell carcinoma.

EGFR deficiency in skin causes hair follicle issues and inflammation.

Nanotechnology can improve cervical cancer treatment by targeting drugs better and reducing side effects.

AP-1 controls tumor cell type by affecting key signaling pathways.

Clinical trials should use innovative designs and biomarkers to improve precision therapy and patient outcomes.

Thymoma with alopecia areata may be linked to abnormal immune cells.

Activin increases skin tumor formation, skin Tregs help hair growth, lymph-node removal doesn't improve melanoma survival, cells can revert to stem cells in wound healing, and skin bacteria produce peptides that may treat infections.

More research and guidelines are needed for managing prostate cancer in people with high-risk genetic mutations.

Androgens increase cervical cancer risk and affect its development.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Men who start losing hair at age 30 may have a lower risk of prostate cancer.

The new drug delivery system effectively targets lung cancer cells.

UC.145 may be a new biomarker for predicting gastric cancer.

The new drug carriers show promise for better targeting and treating ovarian cancer.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Melanocyte stem cells hold promise for skin regeneration and treating pigmentation issues.

Urinary PSA could be an early marker for enlarged prostate.

Gene variation affects prostate issues and hair loss.

Pharmacy professionals need thorough training and guidelines for safely preparing cytotoxic drugs.

5-Alpha reductase inhibitors are safe long-term but may be outdated for preventing less significant prostate cancer.

High-quality data on skin cancer is crucial for understanding its trends and allocating healthcare resources effectively.

Most European physicians know the risks and safe use of Cyproterone acetate, but few remember receiving official safety communications.

ERG increases SOX9, promoting prostate cancer growth and invasion.

TGF-β signaling is crucial for stem cell maintenance, differentiation, and has implications for cancer treatment.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.